Ultrasound stimulation helmet
An ultrasound stimulation helmet ( 100 ) configured to regulate an endogenous neurotrophic factor in a brain or expression of proteins related to a neurodegenerative disease comprises: a main body ( 1 ) having a forehead perimeter adjustment knob ( 12 ), a back head perimeter adjustment knob ( 13 ), a fastening support frame ( 14 ), and multiple position adjustment knobs ( 15 ); and multiple ultrasound probes ( 2 ) detachably mounted on the main body ( 1 ), wherein the ultrasound probe ( 2 ) has a frequency adjustment button and an intensity adjustment button to respectively control an output frequency and output intensity of the ultrasound probe ( 2 ), and other ultrasound parameters and an angle of the ultrasound probe ( 2 ) itself are adjustable as well. The fastening support frame ( 14 ) can be used to adjust the length of the main body ( 1 ) according to the size of a head of a patient, and the ultrasound probes ( 2 ) are connected to the position adjustment knobs ( 15 ) to enable the ultrasound probes ( 2 ) to move upward, downward, or toward the left or right with respect to the head of the patient.
1. An ultrasound stimulation helmet for regulating the expression of a brain endogenous neurotrophic factor or a neurodegenerative disease-related protein, wherein the ultrasound stimulation helmet comprising:
a main body, wherein the main body is wearable on a patient's head, the main body comprising a front adjustment knob, a back adjustment knob, a fastening support frame, and a plurality of position adjustment knobs;
a plurality of ultrasound probes detachably mounted on the main body for generating ultrasound waves, the ultrasound stimulation helmet being characterized in that the ultrasound probes comprise a frequency adjustment knob and an intensity adjustment knob for controlling the output frequency and the output of the ultrasound probe intensity respectively, and other ultrasound parameters and the angle of the ultrasound probe itself are adjustable;
wherein the fastening support frame adjust the length of the main body according to the size of the head of the patient, and the ultrasound probes are connected with the position adjustment knob of the main body so that the ultrasound probes are moved up, down, left and right according to the patient's head; wherein the ultrasound probes are placed in a position which is positioned relative to the patient's temporal trans-orbital, frontal-temporal cortex, temporal window, sub-mandibular, sub-occipital window; wherein the ultrasound probes comprise a switch for turning on or off the ultrasound probe; wherein the frequency of ultrasound wave is between 20K and 10M Hz; wherein the intensity (I SPTA ) of ultrasound wave is between 1 mW/cm 2 and 10 W/cm 2 ; wherein the parameters of the ultrasound probe of the ultrasound stimulation helmet are adjusted to increase or decrease the expression levels of endogenous neurotrophic factor or neurodegenerative disease-related protein in the brain of the subject.
2. The ultrasound stimulation helmet in claim 1 , wherein the feature is the main body comprising a cable fixing portion for fixing the cables of the ultrasound probes.
3. A method for regulating the expression of a brain endogenous neurotrophic factor or a neurodegenerative disease-related protein, comprising:
(1) Placing the ultrasound stimulation helmet of claim 1 on a subject's head;
(2) Adjusting the parameters of the ultrasound probe of the ultrasound stimulation helmet to increase or decrease the expression levels of endogenous neurotrophic factor or neurodegenerative disease-related protein in the brain of the subject.
4. The method of claim 3 , which the parameter of the adjusted ultrasound probe in the step (2) comprising an output intensity (I SPTA ), an output frequency or an action time.
5. The method of claim 4 , wherein the output intensity is between 1 mW/cm 2 and 10 W/cm 2 .
6. The method of claim 4 , wherein the output frequency is between 20K and 10M Hz.
7. The method of claim 4 , wherein the action time is between 30 seconds and 60 minutes.
8. The method of claim 3 , wherein the brain endogenous neurotrophic factor is selected from one or more of the group consisting of brain-derived neurotrophic factor (BDNF), glial cell-derived neurotrophic factor (GDNF), vascular endothelial growth factor (VEGF) and c-fos protein.
9. The method of claim 3 , wherein the neurodegenerative disease-related protein is selected from one or more of the group consisting of TrkB, β-amyloid and acetyl coenzyme A.